Onset of systemic arterial hypertension after initiation of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A case series
Andrea Gramegna, Claudia De Petro, Gloria Leonardi, Martina Contarini, Francesco Amati, R. Meazza, Stefano Carugo, Francesco Blasi
Topics & Concepts
IvacaftorMedicineCystic fibrosisMyocardial fibrosisIntensive care medicineAdverse effectInternal medicineCardiologyPediatricsFibrosisCystic fibrosis transmembrane conductance regulatorCystic Fibrosis Research AdvancesNematode management and characterization studies